Click on image to view larger version.

Figure 1 Event-free survival (death, myocardial infarction, recurrence of symptoms requiring additional revascularization) curves of the two study groups at 12-month follow-up. The rate of event-free survival was significantly higher in the prednisone group than in the placebo group (p < 0.0016 by Cox proportional hazards regression analysis).